Sophia Step Study - a Behaviour Change Program on Physical Activity in Persons With Pre- and Type 2 Diabetes
Health Promotion in the Primary Care Setting- an Evaluation of the Sophia Step Study- a Structured Behaviour Change Program Focusing on Physical Activity in Persons With Pre- and Type 2 Diabetes
1 other identifier
interventional
188
1 country
1
Brief Summary
The aim of the study is to investigate the effects of two levels of primary care physical activity interventions on metabolic control and cardiovascular risk factors, compared to usual care in patients with pre- and type 2 diabetes. The hypothesis is that both levels of interventions have effect on HbA1c with the more intense Group intervention having superior effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable type-2-diabetes
Started Nov 2013
Longer than P75 for not_applicable type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 28, 2015
CompletedFirst Posted
Study publicly available on registry
March 2, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 17, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 17, 2020
CompletedMarch 10, 2020
March 1, 2020
6.3 years
January 28, 2015
March 9, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
HbA1c (mmol/mol)
Haemoglobin A1c
up to month 24.
Secondary Outcomes (21)
fasting plasma glucose (mmol/L)
week 0, 12, 24, and month 9, 12, 18 and 24.
Physical activity level (counts/min)
week 0 and month 6, 12, 18, 24
Steps/day
week 0, 8, 12, 16, 24, and month 9, 12, 18 and 24.
fasting-Insulin (mU/l)
week 0, 12, 24, and month 12 and 24.
LDL (mmol/L)
week 0, 12, 24, and month 12 and 24.
- +16 more secondary outcomes
Other Outcomes (12)
Change in Dietary habits
Evaluation is conducted at baseline and at week 8, 12, 24 and month 12 and 24 after completion of the intervention period
Change in Alcohol habits
Evaluation is conducted at baseline and at week 24 and month 12 and 24 after completion of the intervention period
Change in Stress and working condition
Evaluation is conducted at baseline and at week 12, 24 and month 12 and 24 after completion of the intervention period
- +9 more other outcomes
Study Arms (3)
Group A
EXPERIMENTALParticipants in the intensive intervention group (A) receive a pedometer intervention and 12 group meetings over two years' time, with the majority of meetings being held in the first 6 months. The group meetings constitutes of a 30 min walk and 60 min group consulting based on techniques for behaviour change using an interactive program with positive feed-back following their steps on a website. One occasion is taking place at a gym with instruction for a home-based strength training program. Participants receive 10 individual consultations with a diabetes specialist nurse.
Group B
EXPERIMENTALParticipants in the pedometer group (B) receive a pedometer intervention. Henceforth they are left to continue by they own for two years.
Group C
NO INTERVENTIONThe control group (C) receive diabetes care as usual except for the extra measurements included in the study. Diabetes care as usual is meeting a diabetes specialist nurse and a general practitioner once a year receiving lifestyle advice and physical activity on prescription.
Interventions
Intensive intervention with pedometer. The participants are instructed to set daily step goal and to record their daily steps on a website.
Participants receive 10 individual meetings with a diabetes specialist nurse. Physical activity on prescription is used to set individual goals and to highlight the importance of physical activity.
Eligibility Criteria
You may qualify if:
- Ability to communicate in Swedish Age 40-80 years Type 2 diabetes: Diagnosed type 2 diabetes with a duration of \>=1 year Pre-diabetes: HbA1c \>39-\<47, Fasting plasma glucose \>5.6 mmol/l
You may not qualify if:
- Myocardial infarction in the past 6 months
- serum creatinine \>140
- diabetic ulcer or risk for ulcer
- prescribed insulin in past 6 months
- additional disease prohibiting physical activity
- have experienced repeated hypoglycaemia or severe hypoglycaemia in past 12 months
- classified in very hard-intensity activity according to Stanford Brief Activity Survey
- having no access to internet.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sophiahemmet Universitylead
- Karolinska Institutetcollaborator
- Uppsala Universitycollaborator
- Arizona State Universitycollaborator
Study Sites (1)
Sophiahemmet University
Stockholm, 114 86, Sweden
Related Publications (6)
Rossen J, Yngve A, Hagstromer M, Brismar K, Ainsworth BE, Iskull C, Moller P, Johansson UB. Physical activity promotion in the primary care setting in pre- and type 2 diabetes - the Sophia step study, an RCT. BMC Public Health. 2015 Jul 12;15:647. doi: 10.1186/s12889-015-1941-9.
PMID: 26164092BACKGROUNDLarsson K, Von Rosen P, Rossen J, Johansson UB, Hagstromer M. Relative time in physical activity and sedentary behaviour across a 2-year pedometer-based intervention in people with prediabetes or type 2 diabetes: a secondary analysis of a randomised controlled trial. J Act Sedentary Sleep Behav. 2023 Jun 1;2(1):10. doi: 10.1186/s44167-023-00020-w.
PMID: 40217375DERIVEDLarsson K, Rossen J, Norman A, Johansson UB, Hagstromer M. Predictors associated with an increase in daily steps among people with prediabetes or type 2 diabetes participating in a two-year pedometer intervention. BMC Public Health. 2024 May 11;24(1):1290. doi: 10.1186/s12889-024-18766-6.
PMID: 38734659DERIVEDRossen J, Larsson K, Hagstromer M, Yngve A, Brismar K, Ainsworth B, Aberg L, Johansson UB. Effects of a three-armed randomised controlled trial using self-monitoring of daily steps with and without counselling in prediabetes and type 2 diabetes-the Sophia Step Study. Int J Behav Nutr Phys Act. 2021 Sep 8;18(1):121. doi: 10.1186/s12966-021-01193-w.
PMID: 34496859DERIVEDRossen J, Hagstromer M, Yngve A, Brismar K, Ainsworth B, Johansson UB. Process evaluation of the Sophia Step Study- a primary care based three-armed randomized controlled trial using self-monitoring of steps with and without counseling in prediabetes and type 2 diabetes. BMC Public Health. 2021 Jun 22;21(1):1191. doi: 10.1186/s12889-021-11222-9.
PMID: 34157994DERIVEDRossen J, Von Rosen P, Johansson UB, Brismar K, Hagstromer M. Associations of physical activity and sedentary behavior with cardiometabolic biomarkers in prediabetes and type 2 diabetes: a compositional data analysis. Phys Sportsmed. 2020 May;48(2):222-228. doi: 10.1080/00913847.2019.1684811. Epub 2019 Nov 12.
PMID: 31663410DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Unn-Britt Johansson, Professor
Sophiahemmet University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Unn-Britt Johansson
Study Record Dates
First Submitted
January 28, 2015
First Posted
March 2, 2015
Study Start
November 1, 2013
Primary Completion
February 17, 2020
Study Completion
February 17, 2020
Last Updated
March 10, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share